Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rolapitant in Chronic Idiopathic Cough
NCT00506545Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of rolapitant in chronic idiopathic cough (CIC), sponsored by Merck & Co.. Started Jan 2007; status: completed.
02
Drugs
rolapitant
03
Conditions
chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on NCT00506545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506545.